Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| Sanofi, Novartis, Astrazeneca get poor results from trial tests on key drugs - Washington Post |
 |
 |
|
Washington Post In Basel, Switzerland, Novartis said it was terminating a trial of its high blood pressure treatment Rasilez in high-risk patients with diabetes and renal impairment. The drugmaker said in a statement that it terminated the study on the recommendation ... Novartis announces termination of ALTITUDE study with Rasilez®/ Tekturna® in |
